BIOMAT Database Logo BIOMAT Database Logo

Atrioventricular nodal reentrant paroxysmal supraventricular tachycardia. 1984

L Littmann, and J Tenczer, and T Fenyvesi

UI MeSH Term Description Entries
D008297 Male Males
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D006327 Heart Block Impaired conduction of cardiac impulse that can occur anywhere along the conduction pathway, such as between the SINOATRIAL NODE and the right atrium (SA block) or between atria and ventricles (AV block). Heart blocks can be classified by the duration, frequency, or completeness of conduction block. Reversibility depends on the degree of structural or functional defects. Auriculo-Ventricular Dissociation,A-V Dissociation,Atrioventricular Dissociation,A V Dissociation,A-V Dissociations,Atrioventricular Dissociations,Auriculo Ventricular Dissociation,Auriculo-Ventricular Dissociations,Block, Heart,Blocks, Heart,Dissociation, A-V,Dissociation, Atrioventricular,Dissociation, Auriculo-Ventricular,Dissociations, A-V,Dissociations, Atrioventricular,Dissociations, Auriculo-Ventricular,Heart Blocks
D006329 Heart Conduction System An impulse-conducting system composed of modified cardiac muscle, having the power of spontaneous rhythmicity and conduction more highly developed than the rest of the heart. Conduction System, Heart,Conduction Systems, Heart,Heart Conduction Systems,System, Heart Conduction,Systems, Heart Conduction
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

L Littmann, and J Tenczer, and T Fenyvesi
Atrioventricular nodal reentrant paroxysmal supraventricular tachycardia; a noninvasive diagnosis.
April 1978, Chest,
L Littmann, and J Tenczer, and T Fenyvesi
[Ablation of supraventricular paroxysmal nodal reentrant tachycardia].
December 1993, Cardiologia (Rome, Italy),
L Littmann, and J Tenczer, and T Fenyvesi
[Atrioventricular nodal reentrant tachycardia (AVNRT), atrioventricular junctional reentrant tachycardia].
January 1996, Ryoikibetsu shokogun shirizu,
L Littmann, and J Tenczer, and T Fenyvesi
Paroxysmal complete atrioventricular block during AV nodal reentrant tachycardia.
February 2013, Journal of cardiovascular electrophysiology,
L Littmann, and J Tenczer, and T Fenyvesi
Verapamil in prophylaxis of paroxysmal atrioventricular nodal reentrant tachycardia.
January 1980, Journal of cardiovascular pharmacology,
L Littmann, and J Tenczer, and T Fenyvesi
Effects of quinidine on atrioventricular nodal reentrant paroxysmal tachycardia.
October 1981, Circulation,
L Littmann, and J Tenczer, and T Fenyvesi
Atrioventricular nodal reentrant tachycardia.
July 1984, The Medical clinics of North America,
L Littmann, and J Tenczer, and T Fenyvesi
Atrioventricular nodal reentrant tachycardia.
August 2010, Circulation,
L Littmann, and J Tenczer, and T Fenyvesi
Atrioventricular nodal reentrant tachycardia.
April 1998, Critical care medicine,
L Littmann, and J Tenczer, and T Fenyvesi
Atrioventricular Nodal Reentrant Tachycardia.
January 2017, AACN advanced critical care,
Copied contents to your clipboard!